Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SLC13A5 contributors: mct - updated : 28-02-2014
HGNC name solute carrier family 13 (sodium-dependent citrate transporter), member 5
HGNC id 23089
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver     Homo sapiens
Nervousbrainforebraincerebral cortex   Mus musculus
 brain     Homo sapiens
Reproductivemale systemtestis   
cells
SystemCellPubmedSpeciesStageRna symbol
Digestivehepatocyte Homo sapiens
Nervousneuron Mus musculus
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period fetal
Text liver, eye
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • 11 transmembrane domains
  • conjugated GlycoP
    mono polymer homomer , dimer
    HOMOLOGY
    intraspecies homolog to SLC13A2,SLC13A3
    Homologene
    FAMILY
  • SLC13A transporter family
  • NADC subfamily
  • CATEGORY transport carrier
    SUBCELLULAR LOCALIZATION     plasma membrane
    basic FUNCTION
  • playing an important role in the cellular utilization of citrate in blood for the synthesis of fatty acids and cholesterol (liver) and for the generation of energy (liver and brain)
  • may be facilitating the utilization of circulating citrate for the generation of metabolic energy and for the synthesis of fatty acids and cholesterol
  • tricarboxylate plasma transporter with a preference for citrate
  • primarily a citrate transporter located in the liver and brain, and its activity may regulate metabolic processes
  • CREB-dependent glucagon target gene that is induced in fasting and in type 2 diabetes
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism energetic
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) EIEE25
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    diabetetype 2 
    might be a therapeutic target for the treatment of obesity and type 2 diabetes
    obesity  
    might be a therapeutic target for the treatment of obesity and type 2 diabetes
    ANIMAL & CELL MODELS
  • Nact (also known as Slc13a5)-knockout mice have been found to have increased hepatic mitochondrial biogenesis, higher lipid oxidation and energy expenditure, and reduced lipogenesis, which taken together protect the mice from obesity and insulin resistance
  • mIndy was induced in livers of fasted as well as in high-fat-diet-streptozotocin diabetic rats, in which Creb is constitutively activated. mIndy induction was completely prevented when Creb was depleted in these rats by antisense oligonucleotides